source
- Precision Neuroscience raises $250M in Series D to expand brain-computer interface programPrecision Neurosciences announced a $250 million Series D financing round that was oversubscribed. The capital injection follows previous rounds that have brought the company’s total funding to $43…
- AstraZeneca invests $2 billion for stake in Summit Therapeutics to back its cancer drugAstraZeneca announced on Monday that it will invest $2 billion to acquire a minority equity stake in Summit Therapeutics. The investment gives AstraZeneca a slice of the biotech as the companies mo…